1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

Thumbnail for Impact of Daratumumab-Based Regimens on Survival and Minimal Residual Disease Negativity in Multiple Myeloma: A Systematic Review and Meta-Analysis

MM - 1537

Impact of Daratumumab-Based Regimens on Survival and Minimal Residual Disease Negativity in Multiple Myeloma: A Systematic Review and Meta-Analysis

Anubhuti Sharma

Poster Presenter: Anubhuti Sharma

Thumbnail for Impact of Diabetes Mellitus on Outcomes and Toxicity in Patients With Diffuse Large B-Cell Lymphoma Treated With Bispecific Antibodies: A Real-World Propensity Score-Matched Analysis

ABCL - 1652

Impact of Diabetes Mellitus on Outcomes and Toxicity in Patients With Diffuse Large B-Cell Lymphoma Treated With Bispecific Antibodies: A Real-World Propensity Score-Matched Analysis

Juhi Ardeshna-Chovatiya

Poster Presenter: Juhi Ardeshna-Chovatiya

MM - 1644

Impact of Diabetes Mellitus on Outcomes in Multiple Myeloma Patients Receiving Bispecific Antibodies: A Real-World Analysis

Juhi Ardeshna-Chovatiya

Poster Presenter: Juhi Ardeshna-Chovatiya

ABCL - 003

Impact of Diagnostic Delay on Stage and Treatment Response in High-Grade Lymphomas

Nadjia Benkhira

Poster Presenter: Nadjia Benkhira

CT - 529

Impact of Donor Type on GVHD and Survival in Pediatric Haploidentical HSCT: A 10-Year Single-Center Study

PAULINA GARCIA MALDONADO

Poster Presenter: PAULINA GARCIA MALDONADO

$Thumbnail for Impact of Dose Modifications on Efficacy Outcomes With Belantamab Mafodotin in Relapsed/Refractory Multiple Myeloma: Insights From the DREAMM-7 Third-Line or Later Proteasome Inhibitor/Immunomodulatory Agent-Exposed Subgroup$

MM - 1100

Impact of Dose Modifications on Efficacy Outcomes With Belantamab Mafodotin in Relapsed/Refractory Multiple Myeloma: Insights From the DREAMM-7 Third-Line or Later Proteasome Inhibitor/Immunomodulatory Agent-Exposed Subgroup

Al-Ola Abdallah

Poster Presenter: Al-Ola Abdallah

Video

MPN - 1689

Impact of GLP-1 Agonists on Clinical Outcomes in Patients With Essential Thrombocythemia: A Propensity-Matched Analysis

Nneoma Ubah

Poster Presenter: Nneoma Ubah

$Thumbnail for Impact of Loss of B-Cell Aplasia on Clinical Outcomes Following Talicabtagene Autoleucel in Patients With Relapsed/Refractory B-Cell Malignancies: A Single-Center Real-World Experience$

CT - 1231

Impact of Loss of B-Cell Aplasia on Clinical Outcomes Following Talicabtagene Autoleucel in Patients With Relapsed/Refractory B-Cell Malignancies: A Single-Center Real-World Experience

Sahitya Rao

Poster Presenter: Sahitya Rao

Thumbnail for Impact of Moderate-to-Severe Chronic Kidney Disease on Outcomes After CAR T-Cell Therapy in Multiple Myeloma: A Real-World Propensity Score-Matched Analysis

MM - 1660

Impact of Moderate-to-Severe Chronic Kidney Disease on Outcomes After CAR T-Cell Therapy in Multiple Myeloma: A Real-World Propensity Score-Matched Analysis

Mishaal Munir

Poster Presenter: Mishaal Munir